is semaglutide off the fda shortage list As of February 21, 2025, updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Cheap, compounded versions of Ozempic,

Current literature suggests that KD supports the body's ability to combat oxidative stress by producing ketone bodies, which may alleviate the symptoms of many skin conditions linked to oxidative stress (122)

4 & Metformin generally: Does not cause significant weight gain Has a low risk of causing low blood sugar (when used alone) Supports long-term blood sugar control Chronic diseases like diabetes are increasing globally

It may also help increase levels of this important compound

Patients on brand-name medications pay a separate $25/mo treatment plan fee on top of the medication cost, but no monthly charge is attached to compounded prescriptions